Jpmorgan Chase & CO Generation Bio Co. Transaction History

Jpmorgan Chase & CO

$1.1 Trillion
Q1 2024

A detailed history of Jpmorgan Chase & CO transactions in Generation Bio Co. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 268,078 shares of GBIO stock, worth $755,979. This represents 0.0% of its overall portfolio holdings.

Number of Shares

268,078

Previous 285,886 6.23%

Holding current value

$755,979

Previous $471,000 131.63%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$1.73 - $4.07 $30,807 - $72,478	-17,808 Reduced 6.23%	268,078 $1.09 Million
Q4 2023 Feb 12, 2024	SELL	$0.91 - $3.35 $1.02 Million - $3.77 Million	-1,124,560 Reduced 79.73%	285,886 $471,000
Q3 2023 Nov 14, 2023	BUY	$3.65 - $6.9 $1.86 Million - $3.51 Million	509,129 Added 56.49%	1,410,446 $5.35 Million
Q2 2023 Aug 11, 2023	BUY	$3.5 - $5.67 $1.53 Million - $2.48 Million	437,463 Added 94.31%	901,317 $4.96 Million
Q1 2023 May 18, 2023	BUY	$3.61 - $7.01 $132,985 - $258,234	36,838 Added 8.63%	463,854 $1.99 Million

Q1 2023 May 11, 2023	SELL	$3.61 - $7.01 $123,187 - $239,209	-34,124 Reduced 7.4%	427,016 $1.84 Million
Q4 2022 Feb 13, 2023	BUY	$3.66 - $6.77 $11,217 - $20,750	3,065 Added 0.67%	461,140 $1.81 Million
Q3 2022 Nov 14, 2022	SELL	$4.68 - $8.34 $871,327 - $1.55 Million	-186,181 Reduced 28.9%	458,075 $2.43 Million
Q2 2022 Aug 11, 2022	SELL	$4.87 - $9.41 $78,012 - $150,738	-16,019 Reduced 2.43%	644,256 $4.23 Million
Q1 2022 May 11, 2022	BUY	$4.16 - $7.76 $408,803 - $762,575	98,270 Added 17.49%	660,275 $4.85 Million
Q4 2021 Feb 10, 2022	SELL	$5.99 - $24.97 $7.48 Million - $31.2 Million	-1,247,973 Reduced 68.95%	562,005 $3.98 Million
Q3 2021 Nov 12, 2021	BUY	$20.0 - $27.43 $36.2 Million - $49.6 Million	1,809,978 New	1,809,978 $45.4 Million

Others Institutions Holding GBIO

# of Institutions

Shares Held

49.5M

Call Options Held

20.3K

Put Options Held

View Full List

About Generation Bio Co.

Ticker GBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,011,200
Market Cap $166M
Description
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...

More about GBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Generation Bio Co. Transaction History